A new enterprise, spun off from Seattle Children’s Research Institute, is creating therapeutics for diseases from engineered B-cells in the immune system. . . . → Read More: Start-Up Developing Engineered B-Cell Therapies
|
|||||
|
       
  |
Venture capital funding rose in the third quarter of 2020, driven in large part by investments in already established companies rather than newer enterprises. . . . → Read More: Q3 Venture Funds Inch Up, Early-Stage Deals Drop  Comments are closed  Finance  economics, entrepreneurs, equity, investment, life sciences, venture capital 
A start-up company is using artificial intelligence to discover drugs that address the tumor stroma, a cellular network supporting cancerous tumors. . . . → Read More: New Company IDs Drugs Targeting Cancer Cell Networks One comment - (Comments are closed) Finance biomedical, biotechnology, Canada, cancer, engineering, entrepreneurs, equity, genomics, investment, life sciences, mathematics, pharmaceuticals, physical sciences, venture capital 
A new enterprise is underway developing therapeutics targeting bacterial communities in the body, to treat metabolic disorders and cancer. . . . → Read More: Microbiome Therapies Company Unveils, Raises $50M Comments are closed Finance, New products biomedical, biotechnology, cancer, entrepreneurs, equity, genomics, investment, life sciences, pharmaceuticals, university, venture capital 
The report also highlights where the investments were made, with the geographic hubs or clusters attracting the most investments, this weekend’s infographic. . . . → Read More: Infographic – Global Climate Technology Hubs Comments are closed Finance China, cleantech, energy, entrepreneurs, equity, investment, venture capital 
A company developing messenger RNA therapeutics on demand from single-use biochips is raising $60 million in its second venture funding round. . . . → Read More: Chip-Based RNA Biotech Raises $60M in Venture Funds One comment - (Comments are closed) Finance, New products biomedical, biotechnology, cancer, engineering, entrepreneurs, equity, genomics, investment, life sciences, manufacturing, pharmaceuticals, venture capital 
A company creating cancer therapies with individualized engineered T-cells is raising $110 million in its first venture funding round. . . . → Read More: Precision Cancer Therapy Start-Up Gains $110M in Early Funds One comment - (Comments are closed) Finance, New products biomedical, biotechnology, cancer, entrepreneurs, equity, genomics, investment, life sciences, pharmaceuticals, preclinical, venture capital 
A new enterprise formed to discover human therapeutic antibodies is partnering with a synthetic biology company to discover Covid-19 antibody treatments. . . . → Read More: Antibody Discovery Company Forms, Partners on Covid-19 Comments are closed Finance, Joint ventures/collaborations biomedical, biotechnology, cancer, Covid-19, engineering, entrepreneurs, equity, investment, life sciences, mathematics, pharmaceuticals, physical sciences, venture capital 
A Belgian company creating virtual reality systems for sedation in surgery and invasive procedures is raising €10 million in its first venture funding round. . . . → Read More: Digital Sedation Company Raises $11.8M in Early Funds One comment - (Comments are closed) Finance, New products behavioral science, biomedical, clinical trials, engineering, entrepreneurs, equity, Europe, investment, life sciences, medical device, physical sciences, software, venture capital 
Looking back to May shows that NBI has largely settled in to the 4,000 to 4,500 range, without volatile swings in either direction. . . . → Read More: Infographic – Biotech Index Cruising in High Range |
||||
|
Copyright © 2020 Technology News and Literature - All Rights Reserved Powered by WordPress & Atahualpa |
|||||